An industry perspective on the monitorin
โ
Satish K. Singh; Nataliya Afonina; Michel Awwad; Karoline Bechtold-Peters; Jeffr
๐
Article
๐
2010
๐
John Wiley and Sons
๐
English
โ 399 KB
๐ 1 views
Concern around the lack of monitoring of proteinaceous subvisible particulates in the 0.1-10 mm range has been heightened (Carpenter et al., 2009, J Pharm Sci 98: 1202-1205), primarily due to uncertainty around the potential immunogenicity risk from these particles. This article, representing the op